Bioterrorism-related anthrax: International response by the Centers for Disease Control and Prevention

被引:9
|
作者
Polyak, CS
Macy, JT
Irizarry-De la Cruz, M
Lai, JE
McAuliffe, JF
Popovic, T
Pillai, SP
Mintz, ED
机构
[1] Ctr Dis Control & Prevent, Foodborne & Diarrheal Dis Branch, Atlanta, GA 30333 USA
[2] Dept Hlth, Bur Labs, Miami, FL USA
关键词
D O I
10.3201/eid0810.020345
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
After reports of the intentional release of Bacillus anthracis in the United States, epidemiologists, laboratorians, and clinicians around the world were called upon to respond to widespread political and public concerns. To respond to inquiries from other countries regarding anthrax and bioterrorism, the Centers for Disease Control and Prevention established an international team in its Emergency Operations Center. From October 12, 2001, to January 2, 2002, this team received 130 requests from 70 countries and 2 territories. Requests originated from ministries of health, international organizations, and physicians and included subjects ranging from laboratory procedures and clinical evaluations to assessments of environmental and occupational health risks. The information and technical support provided by the international team helped allay fears, prevent unnecessary antibiotic treatment, and enhance laboratory-based surveillance for bioterrorism events worldwide.
引用
收藏
页码:1056 / 1059
页数:4
相关论文
共 50 条
  • [1] Clinical predictors of bioterrorism-related inhalational anthrax - Response
    Kyriacou, DN
    LANCET, 2005, 365 (9455): : 215 - 215
  • [2] Serious adverse events among participants in the Centers for Disease Control and Prevention's Anthrax Vaccine and antimicrobial availability program for persons at risk for bioterrorism-related inhalational anthrax
    Tierney, BC
    Martin, SW
    Franzke, LH
    Marano, N
    Reissman, DB
    Louchart, RD
    Goff, JA
    Rosenstein, NE
    Sever, JL
    McNeil, MM
    CLINICAL INFECTIOUS DISEASES, 2003, 37 (07) : 905 - 911
  • [3] Pathologic diagnosis of bioterrorism-related cutaneous anthrax
    Shieh, WJ
    Guarner, J
    Paddock, C
    Smith, C
    Tatti, K
    Morken, T
    Greer, P
    Ferebee-Harris, T
    Bartlett, J
    Montague, J
    Zaki, SR
    LABORATORY INVESTIGATION, 2003, 83 (01) : 264A - 264A
  • [4] Pathologic diagnosis of bioterrorism-related cutaneous anthrax
    Shieh, WJ
    Guarner, J
    Paddock, C
    Smith, C
    Tatti, K
    Morken, T
    Greer, P
    Ferebee-Harris, T
    Bartlett, J
    Montague, J
    Zaki, SR
    MODERN PATHOLOGY, 2003, 16 (01) : 264A - 264A
  • [5] Clinical predictors of bioterrorism-related inhalational anthrax
    Gair, R
    LANCET, 2005, 365 (9455): : 214 - 215
  • [6] Pathology and pathogenesis of bioterrorism-related inhalational anthrax
    Guarner, J
    Jernigan, JA
    Shieh, WJ
    Tatti, K
    Flannagan, LM
    Stephens, DS
    Popovic, T
    Ashford, DA
    Perkins, BA
    Zaki, SR
    AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (02): : 701 - 709
  • [7] Clinical predictors of bioterrorism-related inhalational anthrax
    Kyriacou, DN
    Stein, AC
    Yarnold, PR
    Courtney, DM
    Nelson, RR
    Noskin, GA
    Handler, JA
    Frerichs, RR
    LANCET, 2004, 364 (9432): : 449 - 452
  • [8] Centers for Disease Control and Prevention bioterrorism preparedness and response
    Lillibridge, SR
    Bell, AJ
    Roman, RS
    AMERICAN JOURNAL OF INFECTION CONTROL, 1999, 27 (06) : 463 - 464
  • [9] Call-tracking data and the public health response to bioterrorism-related anthrax
    Mott, JA
    Treadwell, TA
    Hennessy, TW
    Rosenberg, PA
    Wolfe, MI
    Brown, CM
    Butler, JC
    EMERGING INFECTIOUS DISEASES, 2002, 8 (10) : 1088 - 1092
  • [10] Detection and prevention of ocular phototoxicity of ciprofloxacin, the prophylactic antidote for bioterrorism-related anthrax.
    Roberts, JE
    Rammal, M
    Smith, F
    Hamilton, MG
    Chignell, CF
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U178 - U178